[{"address1": "Level 9", "address2": "505 Little Collins Street", "city": "Melbourne", "state": "VIC", "zip": "3000", "country": "Australia", "phone": "61 3 9826 0399", "fax": "61 3 9824 0083", "website": "https://opthea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.", "age": 71, "title": "CEO & Chairperson", "yearBorn": 1953, "fiscalYear": 2025, "totalPay": 80000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "irWebsite": "http://www.circadian.com.au/investor-information", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.41, "open": 0.0, "dayLow": 3.41, "dayHigh": 3.41, "regularMarketPreviousClose": 3.41, "regularMarketOpen": 0.0, "regularMarketDayLow": 3.41, "regularMarketDayHigh": 3.41, "payoutRatio": 0.0, "beta": 1.473, "forwardPE": -1.8432432, "volume": 0, "regularMarketVolume": 0, "averageVolume": 0, "averageVolume10days": 0, "averageDailyVolume10Day": 0, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 524820672, "fiftyTwoWeekLow": 3.03, "fiftyTwoWeekHigh": 6.3, "priceToSalesTrailing12Months": 3594.662, "fiftyDayAverage": 3.41, "twoHundredDayAverage": 3.679305, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4397341184, "profitMargins": 0.0, "floatShares": 812201325, "sharesOutstanding": 153906358, "sharesShort": 537846, "sharesShortPriorMonth": 528917, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0034999999, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.04524, "shortPercentOfFloat": 0.0047, "impliedSharesOutstanding": 157340992, "bookValue": -0.163, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -162791008, "trailingEps": -2.25, "forwardEps": -1.85, "enterpriseToRevenue": 30118.773, "enterpriseToEbitda": -28.232, "52WeekChange": -0.12564105, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 3.41, "targetHighPrice": 1.0, "targetLowPrice": 1.0, "targetMeanPrice": 1.0, "targetMedianPrice": 1.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 48443000, "totalCashPerShare": 0.039, "ebitda": -155755008, "totalDebt": 246992992, "quickRatio": 0.217, "currentRatio": 0.22, "totalRevenue": 146000, "revenuePerShare": 0.0, "returnOnAssets": -0.79279, "grossProfits": 146000, "freeCashflow": -165902880, "operatingCashflow": -158644000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": 23549.332, "financialCurrency": "USD", "symbol": "OPT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Opthea Limited", "corporateActions": [], "regularMarketTime": 1749499200, "longName": "Opthea Limited", "regularMarketChangePercent": 0.0, "regularMarketPrice": 3.41, "exchange": "NMS", "messageBoardId": "finmb_2482138", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "earningsTimestampEnd": 1756353600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.25, "epsForward": -1.85, "fiftyDayAverageChange": 0.0, "fiftyDayAverageChangePercent": 0.0, "twoHundredDayAverageChange": -0.269305, "twoHundredDayAverageChangePercent": -0.073194526, "priceToBook": -20.920246, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602855000000, "regularMarketChange": 0.0, "regularMarketDayRange": "3.41 - 3.41", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 0, "fiftyTwoWeekLowChange": 0.3800001, "fiftyTwoWeekLowChangePercent": 0.12541258, "fiftyTwoWeekRange": "3.03 - 6.3", "fiftyTwoWeekHighChange": -2.89, "fiftyTwoWeekHighChangePercent": -0.45873016, "fiftyTwoWeekChangePercent": -12.564105, "earningsTimestamp": 1756353600, "earningsTimestampStart": 1756353600, "displayName": "Opthea", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]